As a new-type foreign trade service provider driven by both technological transformation and export business, HiSiaddi has established a "1+2+3+4=1" service system and can supply erucylamide sourced from multiple well-known original manufacturers.
With over a decade of market experience and technical cooperation with factories, HiSiaddi possesses extensive expertise in product compliance issues. Below is a case of HiSiaddi resolving compliance challenges for erucylamide products.
For inquiries about erucylamide product compliance, please contact HiSiaddi customer service.
Headquartered in Cologne, North Rhine-Westphalia, Germany, BayerPack is a well-established local mid-to-high-end packaging manufacturer focusing on three core product lines: CPP films for premium frozen food, flexible packaging for infant snacks, and medical-grade TPE hoses. Its downstream brand partners include century-old German dairy producers, EU organic infant complementary food brands, and local pharmaceutical manufacturers. The company maintains stable annual erucylamide procurement of 270 tons split into three grades: 155 tons food film grade, 70 tons medical modified TPE grade, 45 tons eco-friendly soybean ink grade. All products must comply with four mandatory EU compliance requirements: REACH Regulation, EU Regulation 10/2011 on food contact materials, CLP chemical labeling regulation, and RoHS 2.0. Raw materials are fully benchmarked against imported erucylamide from AkzoNobel (Netherlands) and Croda (UK). Unlike low-end small buyers with loose compliance audits focused solely on unit price, this enterprise conducts full compliance document review plus third-party on-site sampling inspection before raw material warehousing. Non-compliant full containers face direct return or destruction, leaving near-zero margin for procurement error.
In late 2025, surging European domestic chemical raw material prices and extended overseas manufacturer lead times exceeding 75 days prompted BayerPack to appoint HiSiaddi as its exclusive foreign trade procurement service provider to launch a domestic Chinese erucylamide import substitution program. The client independently contacted three leading domestic erucylamide manufacturers to finalize an initial 60-ton trial order. Shortly before container loading at Shanghai Port, the client’s compliance department issued an official warning letter outlining four major compliance defects preventing normal customs clearance and export. If complete compliance documentation could not be supplemented and product indicators rectified within 30 days, the 60-ton goods would be scrapped on-site, all cooperation canceled, and Chinese supply chain procurement permanently terminated.
Core Compliance Blockages Listed by the Client:
1. REACH Compliance Deficiencies: Supplying factories could only provide basic SGS test reports, lacking formal REACH registration dossiers and full SVHC Substance of Very High Concern screening reports, failing to meet EU ECHA chemical market access rules;
2. Missing Food Contact Compliance Documentation: No dedicated migration test reports or Declarations of Conformity (DoC) under EU Regulation 10/2011, with blank controlled data on erucylamide Specific Migration Limit (SML), failing to meet EU positive list access requirements for food contact materials;
3. Non-Compliant CLP Packaging Labels: Domestic manufacturers printed outer bag labels following China’s national standard format only, lacking GHS Globally Harmonized System chemical classification labels, German safety warning text, violating EU land and ocean dangerous goods packaging specifications;
4. Blank Raw Material Traceability System: EU Regulation 1935/2004 mandates full-chain raw material traceability ledgers, yet manufacturers could not provide source certification for erucic acid rapeseed oil upstream feedstock or production process traceability records, preventing import filing verification.
The three contacted manufacturers all refused rectification on the grounds of “only responsible for production and supply, no supporting international compliance paperwork”. Most could only issue domestic national GB quality inspection slips with limited familiarity with full EU regulation details, leaving the client’s compliance team without Chinese market resources and fully entrusting HiSiaddi to resolve all compliance risks end-to-end.
HiSiaddi formed a dedicated team of compliance specialists, fine chemical technical engineers, and third-party laboratory coordinators to cross-reference full EU regulation provisions and sort root causes of compliance failures, distinguishing objective factory limitations from administrative documentation oversights:
Most domestic erucylamide manufacturers only complete domestic production filings, with only a small number of high-end grades holding formal EU REACH pre-registration. The batch prepared for this order only underwent simplified pre-declaration without complete formal REACH registration dossiers. Factory routine testing only monitors basic physical and chemical indicators (amide content, acid value, color value), never conducting full 242-item SVHC screening per EU requirements, lacking compliant test data on trace impurities including mineral oil aromatic hydrocarbons (MOAH) and trace auxiliary residues. Current EU customs rules ban entry of chemical additives without SVHC reports. Low-volume bulk buyers rarely require full REACH documentation, eliminating routine compliance investment for manufacturers – a frequent bottleneck for domestic additives exported to mid-to-high-end EU clients.
EU Regulation 10/2011 explicitly stipulates a Specific Migration Limit (SML) ≤30mg/kg for erucylamide used in food packaging, requiring full migration testing using three food simulants (water, ethanol, vegetable oil) with dual-language EU-recognized CNAS laboratory test reports and manufacturer Declarations of Conformity (DoC). Domestic manufacturers only conduct factory release testing aligned with China’s GB 9685 national standard, whose test methods and limit values diverge from EU migration standards, rendering domestic reports inadmissible by German customs and client quality control departments.
CLP Regulation mandates solid chemical outer packaging to display CAS number (Erucylamide CAS:112-84-5), GHS hazard pictograms, bilingual German/English safety instructions, emergency contact information, and EU import agent details. Original packaging bags only contained Chinese product names, net weight, and factory addresses without compliant labeling, risking customs detention upon arrival in Europe with high detention and repackaging costs.
Under the EU Regulation 1935/2004 framework, food-grade additives require full retention of purchase receipts, production records, distillation section inspection logs, and finished factory inspection records covering the entire chain from upstream oil procurement, ammonolysis synthesis, molecular distillation refining, to finished product packaging, forming traceable ledgers for EU market product recall verification. Most small and medium domestic manufacturers source raw materials via scattered bulk purchasing with loose ledger management, lacking standardized traceability archives.
Leveraging years of accumulated compliance resources for EU additive exports, HiSiaddi coordinated authorized third-party laboratories (SGS, CIRS) and REACH registration agencies to complete product testing, documentation supplementation, packaging rectification, and traceability filing in phases, forming a closed-loop full-dimensional compliance solution within the agreed timeline.
1. Coordinate supplying factories to retrieve raw material data and process parameters for the product grade, cooperate with EU compliance institutions to complete extended filing of the grade’s REACH pre-registration, issuing formal REACH registration extended use letters confirming product eligibility within the EU chemical access catalog;
2. Submit samples to SGS Shanghai Laboratory for full screening of 242 SVHC high-concern substances per ECHA’s latest list, strictly controlling trace impurities including MOAH mineral oil, phthalates, and heavy metals. Tri-lingual Chinese/English/German SVHC test reports were issued with all measured indicators below EU control limits, uploaded to the ECHA enterprise filing system simultaneously.
1. Submit food-grade and medical-grade samples separately to EU-recognized CNAS laboratories for full migration testing using three EU-standard food simulants. Final measured erucylamide migration volume reached 12.6mg/kg, far below the statutory SML upper limit of 30mg/kg, issuing dual-language migration test reports admissible by EU authorities;
2. HiSiaddi assisted manufacturers in drafting manufacturer Declarations of Conformity (DoC) formatted per EU standards, clarifying applicable product grades, regulatory reference numbers, and raw material compliance commitments, affixed with factory bilingual Chinese/English official seals as mandatory compliance documents for German client warehousing.
1. Redesign product outer bag labels in accordance with CLP Regulation, displaying CAS 112-84-5, GHS no-hazard pictograms, German + English safety warnings, EU import agent contact information, and storage & transportation precautions;
2. Repack unloaded raw materials into compliant packaging bags, affix compliant adhesive labels externally to pre-packed finished goods, archive all rectification photos simultaneously, and issue packaging compliance statements meeting sea and German inland land transport inspection requirements.
HiSiaddi assisted manufacturers in sorting qualification certificates of upstream erucic acid rapeseed oil suppliers, oil purchase receipts, production feeding records, distillation section inspection ledgers, and finished factory inspection records, compiling bilingual Chinese/English traceability manuals aligned with EU traceability specifications to form fully traceable archives covering the entire chain from oil feedstock → intermediate products → finished goods, satisfying traceability verification requirements of German food regulatory authorities.
The complete compliance dossier was organized into three sets of electronic and hard-copy originals respectively for factory retention, client quality control warehousing, and German customs clearance filing.
Before the 30-day rectification deadline, HiSiaddi submitted the full compliance dossier to the client’s German compliance department for audit, which passed internal review in one go, issuing loading authorization for goods. The 60 tons of erucylamide were split into two containers shipped from Shanghai Port to Hamburg Port, Germany. Customs inspection of REACH dossiers, SVHC test reports, food migration testing, CLP labels, and traceability ledgers confirmed full compliance without detention, with goods smoothly delivered to BayerPack’s warehouse center. The client split batches for production across three lines: food films showed no excessive precipitation after 90 days of ambient storage, medical TPE passed 121°C sterilization extractable testing, and eco-friendly inks complied with EU standards during high-speed printing. All finished goods passed domestic German food and medical random inspections.
BayerPack formally reduced annual procurement volumes from AkzoNobel (Netherlands) and signed a 270-ton annual framework procurement contract with HiSiaddi, entrusting HiSiaddi with routine full-batch compliance control: advance completion of corresponding compliance testing before factory release of each batch, annual updates of supplementary SVHC list documentation, and full compliance documentation attached with each shipment. Post-domestication, the client’s overall annual raw material procurement costs fell by 29%, with lead time shortened from 75 days to 32 days, mitigating risks of European raw material geopolitical price hikes and supply disruption. When the client later added customized erucylamide demand for infant complementary food films, HiSiaddi implemented pre-compliance review at the raw material selection stage aligned with EU regulations to eliminate hidden compliance risks in advance.
1.
Common Industry Compliance Pain Points: Domestic Manufacturers Prioritize Production While Neglecting International Compliance The vast majority of domestic erucylamide manufacturers design production standards aligned with China’s national GB standards, lacking reserves on overseas regulations including REACH, EU 10/2011, and CLP. Factories only deliver finished goods without supporting international compliance testing, documentation drafting, and label rectification services. Low-volume scattered foreign trade orders impose no compliance audit requirements, eliminating manufacturer investment in compliance infrastructure. However, mid-to-high-end EU food and medical clients are bound by stringent EU regulations, with full compliance serving as a precondition for procurement. Single production factories cannot independently deliver full-chain compliance implementation, creating high risks of full batch scrapping post-production due to compliance failures.
2.
3.
Unique Compliance Mandates of Mid-to-High-End Clients Distinct From Low-Volume Purchasers Mid-to-high-end EU end enterprises represented by BayerPack serve high-risk product categories including food and infant supplies. Non-compliant raw materials trigger not only full batch scrapping but also downstream finished product recalls and massive brand compensation losses, making full compliance documentation the primary procurement threshold – a core demand absent among low-volume bulk buyers focused solely on unit price.
4.
5.
HiSiaddi’s Core Foreign Trade Value: Act as a Compliance Bridge Between Manufacturers & Overseas Clients Breaking away from the operating model of general commodity intermediaries, HiSiaddi leverages mature overseas regulatory resources and cooperative third-party testing channels to implement front-end full-chain compliance control over raw material export processes, compensating for domestic manufacturers’ gaps in international compliance capacity. One-stop compliance solutions are delivered across four dimensions: REACH registration, food migration testing, packaging label rectification, and traceability ledger establishment, enabling mid-to-high-end overseas clients to smoothly launch domestic substitution while facilitating entry of high-quality domestic mid-to-high-end erucylamide into EU premium supply chains. Irreplaceable core competitiveness is built via integrated compliance services.
6.
For inquiries about erucylamide product compliance, please contact HiSiaddi customer service.
+86-13120989737 
info@hisiaddi.com 
English
